Tuesday 15 December 2015

Global Biologic Therapeutics Industry 2015 - 2019 Forecast and Overview


Biologic therapeutics include virus, therapeutic serums, toxins, allergenic products, antitoxin, blood components or derivatives, vaccines, blood, and proteins (except any chemically synthesized polypeptide). They also include analogous products, arsphenamine, or derivatives of arsphenamine (or any other trivalent organic arsenic compound) for the prevention, treatment, or cure of a disease. The differences between the biologics and small molecules include the molecular weight, structure, procedure of synthesis, and immunogenicity. Biologics have a higher molecular weight and a complex molecular structure. They are usually derived from living entities, which is another important feature that differentiates it from small molecules. Biologics are also vulnerable to extreme temperatures (thermolabile) and light.


Covered in this report
This report covers the present scenario and the growth prospects of the global biologic therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales protein therapeutics (monoclonal antibodies, enzymes, and other protein therapeutics).
Other protein therapeutics covers proteins such as cytokines, fusion proteins, peptide antibiotics, peptide hormones, and blood factors.
The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market. The vendor landscape section includes a market share analysis of the major vendors along with the competitive performances of their product portfolios.

Table Of Content

PART 01: Executive summary
 Highlights
PART 02: Scope of the report
 Market overview
 Top-vendor offerings

Request A Sample copy of This Report @ http://www.hexareports.com/sample/57538

PART 03: Market research methodology
 Research methodology
 Economic indicators
PART 04: Introduction
 Key market highlights
PART 05: Market landscape
 Market overview
 Market size and forecast
 Five forces analysis
PART 06: Market segmentation by type of molecules
PART 07: Global protein therapeutics market
 Introduction
 Drivers, challenges, and trends
 Market segmentation by type of molecules
PART 08: Global vaccines market
 Introduction
 Drivers, challenges, and trends
 Market segmentation by end-user age group
PART 09: Global cell therapy market
 Introduction
 Drivers, challenges, and trends
 Market size and forecast
PART 10: Geographical segmentation
 Biologic therapeutics market in Americas
 Biologic therapeutics market in EMEA
 Biologic therapeutics market in APAC


About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Information:

Ryan Shaw

Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075

No comments:

Post a Comment